Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- Details
- Category: Clinical Trials
![Schering-Plough Corp. Schering-Plough Corp.](http://www.worldpharmanews.com/images/stories/logo/schering-plough.gif)
Bayer files patent infringement lawsuit against Teva
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
IRESSA (Gefitinib) Receives Marketing Authorisation in Europe
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
More Pharma News ...
- Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities
- Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia
- Sutent Significantly Improved Progression-Free Survival
- GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
- New biological therapy Ilaris® approved in US
- Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission
- GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd